Dear Sir, Recently B. Vialettes et al. published the results of a study to determine the value of low acute insulin response to intravenous glucose as a marker of early stages of Type i (insulin-dependent) diabetes mellitus [1] .
In their article the authors raise the question, whether low acute insulin response is a reliable marker of pre Type 1 diabetes in young patients. In their conclusion they state, that a low acute insulin response to glucose is a sensitive but not specific marker of early stages of Type 1 diabetes. They based their results on a population of 39 individuals with mild or transient hyperglycaemia with fasting blood-glucose levels between 7.7 and 10.0 mmol/1 by two separate measurements. According to WHO criteria they can thus be classified as diabetic patients [2] . The population was followed for three years. They state that at the end of this period the patients were insulin-dependent. This insulin-dependency however, is not defined and seems to be nothing more than insulin treated.
In a group of 150 first degree relatives of Type I diabetic patients only two persons became diabetic. Obviously this number is too low to make a reliable estimate of sensitivity and specificity. 
Response from the authors
Dear Sir, We are only partly in agreement with Dr. Razenberg's statement. We readily admit that the small number of diabetic subjects appearing in our cohort of relatives of Type I (insulin-dependent) diabetic patients during the 3 years does not allow us to assert that low acute insulin response to glucose (LAIR) is a sensitive marker of evolution to Type 1 diabetes in the near future [1] . However, if one pools our two cases to the four reported by Ganda [2] and the seven by Chase [3] , it would appear that LAIR is a common feature of pre-Type 1 diabetes. With regards to the poor specificity of LAIR, we do think that our data allows this conclusion. Prevalence of LAIR is almost twice that of the theoretical risk of diabetes in this population of relatives of Type 1 diabetic patients. Obviously not all the subjects with LAIR will become diabetic in the future. Finally, our paper stresses that some relatives of Type 2 diabetic patients may also exhibit the same anomaly of the insulin response.
Yours sincerely, B. Vialettes, C. Mattal-Zevaco and Ph. Vague
